ctrl K

CG Oncology Inc. Common s... (CGON)

NASDAQ: CGON · Real-Time Price · USD

27.76

0.82 (3.04%)

At close: May 01, 2025, 3:59 PM

27.42

-1.22%

After-hours: May 01, 2025, 07:43 PM EDT

CG Oncology Common stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1.14M	204K	191K	10.36M
Cost of Revenue	32K	n/a	15K	10K
Gross Profit	1.11M	204K	176K	10.35M
Operating Income	-114.67M	-55.45M	-35.25M	-12.61M
Interest Income	26.62M	n/a	n/a	n/a
Pretax Income	-88.04M	-48.61M	-35.44M	-12.84M
Net Income	-88.04M	-48.61M	-35.44M	-12.84M
Selling & General & Admin	33.7M	9.9M	6.39M	4.63M
Research & Development	82.1M	45.75M	29.03M	18.32M
Other Expenses	n/a	n/a	-196K	218K
Operating Expenses	115.81M	55.65M	35.42M	22.95M
Interest Expense	n/a	n/a	1K	451K
Selling & Marketing Expenses	n/a	n/a	-15K	-10K
Cost & Expenses	115.81M	55.65M	35.44M	22.96M
Income Tax Expense	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	62.5M	66.64M	66.64M	66.64M
Shares Outstanding (Diluted)	62.5M	66.64M	66.64M	66.64M
EPS (Basic)	-1.41	-0.73	-0.53	-0.19
EPS (Diluted)	-1.41	-0.73	-0.53	-0.19
EBITDA	-114.67M	-55.43M	-35.23M	-12.38M
EBIT	-114.67M	-55.45M	-35.25M	-12.39M
Depreciation & Amortization	n/a	17K	15K	10K